A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.
| Autor: | Welliver C; Albany Medical College, Albany, New York., MacLachlan LS; Lahey Clinic, Burlington, Massachusetts., Riggs S; Atrium Health, Charlotte, North Carolina., Kukreja JB; University of Colorado, Boulder, Colorado., Miles-Thomas J; Urology of Virginia, Virginia Beach, Virginia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Urology practice [Urol Pract] 2024 Nov; Vol. 11 (6), pp. 950-955. Date of Electronic Publication: 2024 Jul 02. |
| DOI: | 10.1097/UPJ.0000000000000654 |
| Abstrakt: | Introduction: Guidelines for benign prostatic hyperplasia (BPH) were initially formulated by the AUA to provide evidence-based reasoning for the management and care of men suffering from lower urinary tract symptoms due to BPH. Recommendations for a urinalysis and validated symptom questionnaire (AUA Symptom Score [AUASS]/International Prostate Symptom Score [IPSS]) have been long standing, making these data points a metric for examining guidelines adherence. Methods: A survey assessed providers' awareness of AUA BPH guidelines and practice patterns, and was sent to a randomly selected portion of the AUA membership. The AUA Quality (AQUA) Registry was queried to assess testing and practice patterns. Results: Of 4884 invitations sent, 404 responses were received. Most survey respondents (91.8%) indicate they intend to get a urinalysis at initial evaluation. AQUA data found urinalysis was obtained in only 22.8% of patients. Symptom questionnaire use increased with increasing guideline familiarity, with 95.7% of those who are "extremely familiar" routinely using AUASS/IPSS compared to only 69.4% who are "somewhat familiar" ( P < .005). Utilization increased by a factor of 2.7 ( P < .005) for each increment in familiarity. The lowest use of AUASS/IPSS was in the group within 5 years of finishing training ( P = .069). Conclusions: Discrepancies are noted between our practice survey and AQUA data. The AUASS/IPSS is less commonly used by providers with less guideline familiarity and in providers with the least clinical experience. The intent to obtain urinalysis is high; however, actual testing is unfortunately infrequent. These findings could point toward the need for increasing education of providers with regard to clinical guidelines. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|